AGN post-mortem: From 1/1/98 (when David Pyott became CEO) to the buyout by ACT at a nominal price of $219/sh, AGN generated a shareholder return of 3600%, adjusted for splits, dividends, and the spin-off of Advanced Medical Optics* in 2002.
*Now part of ABT.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.